Skip to main content

Table 1 Treatment with rhAPC: survival rate, risk of death and side effects

From: Blending science and compassion: The 30th educational symposium of the Society of Critical Care Medicine, San Francisco, USA, 10-14 February 2001

 

Placebo n = 840

rhAPC n = 850

28 day mortality

30.83%

24.77%

Relative risk of death

Not applicable

19.43% reduction

Survival odds

Not applicable

38.1% increase

Serious bleed event

2.0%

3.5% (P = 0.06)

Back to article page

Critical Care

ISSN: 1364-8535